Visceral hypersensitivity in female but not in male serotonin transporter knockout rats

Neurogastroenterology and Motility

Volumn 25, Issue 6, 2013, Pages

  Galligan, J J ^a,b   Patel, B A ^c   Schneider, S P ^b   Wang, H ^b   Zhao, H ^b   Novotny, M ^b   Bian, X ^a   Kabeer, R ^a   Fried, D ^a   Swain, G M ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Amperometry; Electrophysiology; Sensory neurons; Visceral sensation

Indexed keywords

FLUOXETINE; SEROTONIN; SEROTONIN TRANSPORTER;

AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DIGESTIVE SYSTEM ELECTROPHYSIOLOGY; ELECTROMYOGRAPHY; ESTRUS CYCLE; EVOKED MUSCLE RESPONSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERSENSITIVITY; INTESTINE INNERVATION; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SEX DIFFERENCE; VISCERAL HYPERSENSITIVITY; VISCEROMOTOR RESPONSE;

ACTION POTENTIALS; ANIMALS; COLON; FEMALE; HYPERALGESIA; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX CHARACTERISTICS;

EID: 84878014964     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12133     Document Type: Article

References (48)

1. Akbar A, Walters JR, Ghosh S. Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents. Aliment Pharmacol Ther 2009; 30: 423-35.
2. Grundy D. 5-HT system in the gut: roles in the regulation of visceral sensitivity and motor functions. Eur Rev Med Pharmacol Sci 2008; 12 (Suppl. 1): 63-7.
3. Gershon MD, Tamir H. Release of endogenous 5-hydroxytryptamine from resting and stimulated enteric neurons. Neuroscience 1981; 6: 2277-86.
4. Racke K, Reimann A, Schworer H, Kilbinger H. Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 1996; 73: 83-7.
5. Bertrand PP, Bertrand RL. Serotonin release and uptake in the gastrointestinal tract. Auton Neurosci 2010; 153: 47-57.
6. Wade PR, Chen J, Jaffe B, Kassem IS, Blakely RD, Gershon MD. Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 1996; 16: 2352-64.
7. Camilleri M, Chey WY, Mayer EA et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med 2001; 161: 1733-40.
8. 4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome. Neurogastroenterol Motil 2011; 23: 754-e332.
9. Clavé P. Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutic effects from heterogeneous pharmacological targets. Neurogastroenterol Motil 2011; 23: 1051-5.
10. Coates MD, Mahoney CR, Linden DR et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004; 126: 1657-65.
11. Kerckhoffs AP, ter Linde JJ, Akkermans LM, Samsom M. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am J Physiol 2012; 302: G1053-60.
12. Camilleri M, Andrews CN, Bharucha AE et al. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology 2007; 132: 17-25.
13. Foley S, Garsed K, Singh G et al. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology 2011; 140: 1434-43.e1.
14. Kerckhoffs AP, Ter Linde JJ, Akkermans LM, Samsom M, Trypsinogen IV. serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil 2008; 20: 900-7.
15. Spiller R, Bennett A. Searching for the answer to irritable bowel syndrome in the colonic mucosa: SERTainty and unSERTainty. Gastroenterology 2007; 132: 437-41.
16. Heils A, Teufel A, Petri S et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621-4.
17. Pata C, Erdal ME, Derici E, Yazar A, Kanik A, Ulu O. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol 2002; 97: 1780-4.
18. Yeo A, Boyd P, Lumsden S et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004; 53: 1452-8.
19. Park JM, Choi MG, Park JA et al. Serotonin transporter gene polymorphism and irritable bowel syndrome. Neurogastroenterol Motil 2006; 18: 995-1000.
20. Wang YM, Chang Y, Chang YY et al. Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients. Neurogastroenterol Motil 2012; 24: 560-5.
21. Kohen R, Jarrett ME, Cain KC et al. The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndrome. Dig Dis Sci 2009; 54: 2663-70.
22. Van Kerkhoven LA, Laheij RJ, Jansen JB. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26: 979-86.
23. Park CS, Uhm JH. Polymorphisms of the serotonin transporter gene and G-protein β3 subunit gene in Korean children with irritable bowel syndrome and functional dyspepsia. Gut Liver 2012; 6: 223-8.
24. Houghton LA, Lea R, Jackson N, Whorwell PJ. The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 2002; 50: 471-4.
25. Chang L, Mayer EA, Labus JS, Schmulson M, Lee OY, Olivas TI. Effect of sex on perception of rectosigmoid stimuli in irritable bowel syndrome. Am J Physiol 2006; 291: R277-81.
26. Houghton LA, Brown H, Atkinson W et al. 5-hydroxytryptamine signalling in irritable bowel syndrome with diarrhoea: effects of gender and menstrual status. Aliment Pharmacol Ther 2009; 30: 919-29.
27. 3 receptors in the enteric neurons of mice lacking the serotonin transporter. Am J Physiol 2002; 283: G1398-411.
28. Chen JJ, Li Z, Pan H et al. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J Neurosci 2001; 21: 6348-61.
29. Annaházi A, Gecse K, Dabek M et al. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain 2009; 144: 209-17.
30. Larsson M, Arvidsson S, Ekman C, Bayati A. A model for chronic quantitative studies of colorectal sensitivity using balloon distension in conscious mice-effects of opioid receptor agonists. Neurogastroenterol Motil 2003; 15: 371-81.
31. Greenwood-Van Meerveld B, Venkova K, Hicks G, Dennis E, Crowell MD. Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension. Neurogastroenterol Motil 2006; 18: 76-86.
32. 3 receptors in a rat model of delayed stress-induced visceral hyperalgesia. Pain 2007; 130: 56-65.
33. Homberg JR, Olivier JD, Smits BM et al. Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 2007; 146: 1662-76.
34. Olivier JD, Van Der Hart MG, Van Swelm RP et al. A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 2008; 152: 573-84.
35. Bian X, Patel B, Dai X, Galligan JJ, Swain G. High mucosal serotonin availability in neonatal guinea pig ileum is associated with low serotonin transporter expression. Gastroenterology 2007; 132: 2438-47.
36. Lai J, Porreca F, Hunter JC, Gold MS. Voltage-gated sodium channels and hyperalgesia. Annu Rev Pharmacol Toxicol 2004; 44: 371-97.
37. 3 receptors. J Physiol 2002; 544: 861-9.
38. Coldwell JR, Phillis BD, Sutherland K, Howarth GS, Blackshaw LA. Increased responsiveness of rat colonic splanchnic afferents to 5-HT after inflammation and recovery. J Physiol 2007; 579: 203-13.
39. Lu CL, Hsieh JC, Tsaur ML et al. Estrogen rapidly modulates mustard oil-induced visceral hypersensitivity in conscious female rats: a role of CREB phosphorylation in spinal dorsal horn neurons. Am J Physiol 2007; 292: G438-46.
40. Lu CL, Hsieh JC, Dun NJ et al. Estrogen rapidly modulates 5-hydroxytrytophan-induced visceral hypersensitivity via GPR30 in rats. Gastroenterology 2009; 137: 1040-50.
41. Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 2010; 204: 105-1014.
42. Blaustein JD. Neuroendocrine regulation of feminine sexual behavior: lessons from rodent models and thoughts about humans. Ann Rev Psychol 2008; 59: 93-118.
43. Bradesi S, Eutamene H, Garcia-Villar R, Fioramonti J, Bueno L. Stress-induced visceral hypersensitivity in female rats is estrogen-dependent and involves tachykinin-1 receptors. Pain 2003; 102: 227-34.
44. Ji Y, Tang B, Traub RJ. Modulatory effects of estrogen and progesterone on colorectal hyperalgesia in the rat. Pain 2005; 117: 433-42.
45. Sanoja R, Cervero F. Estrogen-dependent changes in visceral afferent sensitivity. Auton Neurosci 2010; 153: 84-9.
46. Heitkemper MM, Chang L. Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med 2009; 6 (Suppl. 2): 152-67.
47. V1.9 knockout mice. Eur J Pain 2008; 12: 934-44.
48. Grabauskas G, Heldsinger A, Wu X, Xu D, Zhou S, Owyang C. Diabetic visceral hypersensitivity is associated with activation of mitogen-activated kinase in rat dorsal root ganglia. Diabetes 2011; 60: 1743-51.